Schedule Crashers

How to identify and mitigate risks to keep your timeline on track. Biopharma companies can be an optimistic bunch – at least at the beginning of a project. When they find a molecule that shows promise, they are eager to get it to market as quickly as possible – and...

Sound Clinical Strategies: Wwwwwh?

How asking the right questions during clinical development planning can prevent costly mistakes down the line.   When a biopharma company, and its investors, get excited about a new molecule, it can be easy to dive straight into clinical development. The sooner...